Correlations between tumor mutation burden and immune infiltrates and their prognostic value in pancreatic cancer by bioinformatic analysis
- 16 April 2021
- journal article
- research article
- Published by Elsevier BV in Life Sciences
- Vol. 277, 119505
- https://doi.org/10.1016/j.lfs.2021.119505
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung CancerCancer Discovery, 2017
- Primary, Adaptive, and Acquired Resistance to Cancer ImmunotherapyCell, 2017
- Systemic Immunity Is Required for Effective Cancer ImmunotherapyCell, 2017
- Dendritic cell-based immunotherapyCell Research, 2016
- Current progress in immunotherapy for pancreatic cancerCancer Letters, 2016
- Immunotherapy for lung cancerRespirology, 2016
- Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotypeJCI Insight, 2016
- Cancer immunotherapy via dendritic cellsNature Reviews Cancer, 2012
- Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating AgentsClinical Cancer Research, 2011
- How To Build and Interpret a Nomogram for Cancer PrognosisJournal of Clinical Oncology, 2008